ABSTRACT
BACKGROUND: The most common breast cancer detection modalities are generally limited by radiation exposure, discomfort, high costs, inter-observer variabilities in image interpretation, and low sensitivity in detecting cancer in dense breast tissue. Therefore, there is a clear need for an affordable and effective adjunct modality that can address these limitations. The Cyrcadia Breast Monitor (CBM) is a non-invasive, non-compressive, and non-radiogenic wearable device developed as an adjunct to current modalities to assist in the detection of breast tissue abnormalities in any type of breast tissue. METHODS: The CBM records thermodynamic metabolic data from the breast skin surface over a period of time using two wearable biometric patches consisting of eight sensors each and a data recording device. The acquired multi-dimensional temperature time series data are analyzed to determine the presence of breast tissue abnormalities. The objective of this paper is to present the scientific background of CBM and also to describe the history around the design and development of the technology. RESULTS: The results of using the CBM device in the initial clinical studies are also presented. Twenty four-hour long breast skin temperature circadian rhythm data was collected from 93 benign and 108 malignant female study subjects in the initial clinical studies. The predictive model developed using these datasets could differentiate benign and malignant lesions with 78% accuracy, 83.6% sensitivity and 71.5% specificity. A pilot study of 173 female study subjects is underway, in order to validate this predictive model in an independent test population. CONCLUSIONS: The results from the initial studies indicate that the CBM may be valuable for breast health monitoring under physician supervision for confirmation of any abnormal changes, potentially prior to other methods, such as, biopsies. Studies are being conducted and planned to validate the technology and also to evaluate its ability as an adjunct breast health monitoring device for identifying abnormalities in difficult-to-diagnose dense breast tissue.
Subject(s)
Breast Neoplasms , Wearable Electronic Devices , Breast Density , Breast Neoplasms/diagnosis , Female , Humans , Mammography , Pilot ProjectsABSTRACT
Characterization of carotid atherosclerosis and classification into either symptomatic or asymptomatic is crucial in terms of diagnosis and treatment planning for a range of cardiovascular diseases. This paper presents a computer-aided diagnosis (CAD) system (Atheromatic) that analyzes ultrasound images and classifies them into symptomatic and asymptomatic. The classification result is based on a combination of discrete wavelet transform, higher order spectra (HOS) and textural features. In this study, we compare support vector machine (SVM) classifiers with different kernels. The classifier with a radial basis function (RBF) kernel achieved an average accuracy of 91.7% as well as a sensitivity of 97%, and specificity of 80%. Thus, it is evident that the selected features and the classifier combination can efficiently categorize plaques into symptomatic and asymptomatic classes. Moreover, a novel symptomatic asymptomatic carotid index (SACI), which is an integrated index that is based on the significant features, has been proposed in this work. Each analyzed ultrasound image yields on SACI number. A high SACI value indicates that the image shows symptomatic and low value indicates asymptomatic plaques. We hope this SACI can support vascular surgeons during routine screening for asymptomatic plaques.
Subject(s)
Diagnosis, Computer-Assisted/methods , Plaque, Atherosclerotic/diagnostic imaging , Adult , Aged , Aged, 80 and over , Algorithms , Carotid Stenosis/classification , Carotid Stenosis/diagnosis , Carotid Stenosis/diagnostic imaging , Female , Humans , Image Interpretation, Computer-Assisted , Male , Middle Aged , Plaque, Atherosclerotic/classification , Plaque, Atherosclerotic/diagnosis , Support Vector Machine , Ultrasonography , Wavelet AnalysisABSTRACT
In this work, we present a Computer Aided Diagnostic (CAD) technique (a class of Atheromatic systems) that classifies the automatically segmented carotid far wall Intima-Media Thickness (IMT) regions along the common carotid artery into symptomatic and asymptomatic classes. We extracted texture features based on Local Binary Patterns (LBP) and Law's Texture Energy (LTE) and used the significant features to train and test the Support Vector Machine classifier. We developed the classifiers using three-fold stratified cross validation data resampling technique on 342 IMT wall regions. An accuracy of 89.5% was registered. Thus, the proposed technique is accurate, robust, non-invasive, fast, objective, and cost-effective, and hence, will add more value to the existing carotid plaque diagnostics protocol.
Subject(s)
Carotid Intima-Media Thickness , Diagnosis, Computer-Assisted/methods , Algorithms , Biostatistics , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/diagnostic imaging , Carotid Artery, Common/diagnostic imaging , Humans , Plaque, Atherosclerotic/diagnosis , Plaque, Atherosclerotic/diagnostic imaging , Support Vector MachineABSTRACT
In this work, we present a Computer Aided Diagnosis (CAD) based technique for automatic classification of benign and malignant thyroid lesions in 3D contrast-enhanced ultrasound images. The images were obtained from 20 patients. Fine needle aspiration biopsy and histology confirmed malignancy. Discrete Wavelet Transform (DWT) and texture based features were extracted from the thyroid images. The resulting feature vectors were used to train and test three different classifiers: K-Nearest Neighbor (K-NN), Probabilistic Neural Network (PNN), and Decision Tree (DeTr) using ten-fold cross validation technique. Our results show that combination of DWT and texture features in the K-NN classifier resulted in a classification accuracy of 98.9%, a sensitivity of 98%, and a specificity of 99.8%. Thus, the preliminary results of the proposed technique show that it could be adapted as an adjunct tool that can give valuable second opinions to the doctors regarding the nature of the thyroid nodule. The technique is cost-effective, non-invasive, fast, completely automated and gives more objective and reproducible results compared to manual analysis of the ultrasound images. We however intend to establish the clinical applicability of this technique by evaluating it with more data in the future.
Subject(s)
Diagnosis, Computer-Assisted/methods , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/diagnosis , Thyroid Nodule/diagnostic imaging , Thyroid Nodule/diagnosis , Contrast Media , Decision Trees , Diagnosis, Differential , Humans , Image Interpretation, Computer-Assisted , Imaging, Three-Dimensional , Neural Networks, Computer , Thyroid Neoplasms/classification , Thyroid Nodule/classification , Ultrasonography , Wavelet AnalysisABSTRACT
In this paper, we present a Computer Aided Diagnosis (CAD) based technique (Atheromatic system) for classification of carotid plaques in B-mode ultrasound images into symptomatic or asymptomatic classes. This system, called Atheromatic, has two steps: (i) feature extraction using a combination of Discrete Wavelet Transform (DWT) and averaging algorithms and (ii) classification using Support Vector Machine (SVM) classifier for automated decision making. The CAD system was built and tested using a database consisting of 150 asymptomatic and 196 symptomatic plaque regions of interests which were manually segmented. The ground truth of each plaque was determined based on the presence or absence of symptoms. Three-fold cross-validation protocol was adapted for developing and testing the classifiers. The SVM classifier with a polynomial kernel of order 2 recorded the highest classification accuracy of 83.7%. In the clinical scenario, such a technique, after much more validation, can be used as an adjunct tool to aid physicians by giving a second opinion on the nature of the plaque (symptomatic/asymptomatic) which would help in the more confident determination of the subsequent treatment regime for the patient.